ERBB2 and breast cancer: The second and most important result of the study was to demonstrate that the immunization of HER-2/neu transgenic mice with DNA plasmids encoding HER-2/neu oncoprotein in young age induced a protective immunity that can be maintained during life-span through BI and that can significantly prevent the development of mammary cancers spontaneously appearing in HER-2/neu transgenic mice.